The Global non opioid pain treatment market is estimated to be valued at US$ 43.67 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024 to 2031.Key Takeaways Key players operating in the global non opioid pain treatment are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd. , Sun Pharmaceutical Industries Ltd., Cipla Inc.,...